1. Home
  2. BNTC vs LPA Comparison

BNTC vs LPA Comparison

Compare BNTC & LPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • LPA
  • Stock Information
  • Founded
  • BNTC 1995
  • LPA 2013
  • Country
  • BNTC United States
  • LPA United States
  • Employees
  • BNTC N/A
  • LPA N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • LPA
  • Sector
  • BNTC Health Care
  • LPA
  • Exchange
  • BNTC Nasdaq
  • LPA Nasdaq
  • Market Cap
  • BNTC 352.5M
  • LPA 211.9M
  • IPO Year
  • BNTC N/A
  • LPA N/A
  • Fundamental
  • Price
  • BNTC $13.74
  • LPA $6.16
  • Analyst Decision
  • BNTC Strong Buy
  • LPA
  • Analyst Count
  • BNTC 7
  • LPA 0
  • Target Price
  • BNTC $24.71
  • LPA N/A
  • AVG Volume (30 Days)
  • BNTC 37.1K
  • LPA 22.6K
  • Earning Date
  • BNTC 05-16-2025
  • LPA 05-14-2025
  • Dividend Yield
  • BNTC N/A
  • LPA N/A
  • EPS Growth
  • BNTC N/A
  • LPA N/A
  • EPS
  • BNTC N/A
  • LPA N/A
  • Revenue
  • BNTC N/A
  • LPA $43,862,372.00
  • Revenue This Year
  • BNTC N/A
  • LPA N/A
  • Revenue Next Year
  • BNTC N/A
  • LPA N/A
  • P/E Ratio
  • BNTC N/A
  • LPA N/A
  • Revenue Growth
  • BNTC N/A
  • LPA 11.22
  • 52 Week Low
  • BNTC $5.74
  • LPA $6.00
  • 52 Week High
  • BNTC $16.90
  • LPA $525.00
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 51.06
  • LPA N/A
  • Support Level
  • BNTC $13.10
  • LPA N/A
  • Resistance Level
  • BNTC $15.69
  • LPA N/A
  • Average True Range (ATR)
  • BNTC 0.73
  • LPA 0.00
  • MACD
  • BNTC -0.01
  • LPA 0.00
  • Stochastic Oscillator
  • BNTC 24.71
  • LPA 0.00

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About LPA Logistic Properties of the Americas

Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.

Share on Social Networks: